#liver cancer

Opdivo Immunotherapy Improves Survival for People With Liver Cancer

Benefits include lower rates of cancer recurrence and microvascular invasion, which is associated with poor post-surgery outcomes.

Women with the chronic condition are 6 percent more likely than men to develop cancer.

This includes a higher risk of liver cancer, cirrhosis-related complications and death.

Twice as many patients were alive 18 months after starting treatment.

Liver cancer rates and deaths have doubled in the United States, Canada, Australia and United Kingdom.

Scientific evidence does not support warning signs about acrylamide cancer risk.

Non-alcoholic fatty liver disease can lead to cirrhosis and liver cancer.

Findings shed light on mechanisms that lead to liver cancer and for approaches to treat them.

October is Liver Cancer Awareness Month.

Engineered T cells prevent recurrence over five years.

The annual scientific meeting on liver health revealed exciting new findings concerning the battle against the hep C epidemic.

Adding internal radiation or TACE did appear to help certain people, however.

This is according to a recent mathematical modeling study.

Liver cancer development is strongly associated with hep B.

Hepatitis B and C are declining as causes of liver cancer and liver transplants.